Acute uric acid nephropathy (Q28249226)

Medical Clinics of North America

Europe PubMed Central

title

Acute uric acid nephropathy (English)

0 references

1 reference

J D Conger

1

0 references

language of work or name

English

0 references

publication date

July 1990

0 references

published in

0 references

volume

74

0 references

issue

4

0 references

page(s)

859-71

0 references

cites work

Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

A micropuncture study of the early phase of acute urate nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Postsecretory reabsorption of urate in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Renal excretion of urate in mongrel and Dalmatian dogs: a micropuncture study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

7 January 2021

Hyperuricemia and gout

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Paradoxical effects of pyrazinoate and nicotinate on urate transport in dog renal microvillus membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Prevention and management of acute hyperuricemia in childhood leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Hyperuricemic acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Urate deposition disease. How is it regulated and how can it be modified?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Use of allopurinol in preventing hyperuricemia in leukemia and lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Dissolution of Uric Acid Calculi with Systemic Alkalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Renal disease from excess uric acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Serum uric acid in essential hypertension: an indicator of renal vascular involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Influence of the kidney upon urate homeostasis in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3

Allopurinal and acute uric acid nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930522-3